Dan-Yu Lin

Featured in: Favicon

biomedcentral.com Favicon

jamanetwork.com Favicon

thelancet.com Favicon

genomemedicine.biomedcentral.com

Articles

Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA

Mar 4, 2024 | thelancet.com | Dan-Yu Lin |Shuaiqi Huang |Alex Milinovich

1US Food and Drug AdministrationFDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants.
Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections

Sep 21, 2023 | jamanetwork.com | Dan-Yu Lin |Francois Abi Fadel |Shuaiqi Huang

Key PointsQuestion What outcomes are associated with ritonavir-boosted nirmatrelvir or molnupiravir use for outpatient treatment of SARS-CoV-2 Omicron subvariants, particularly BQ.1.1 and XBB.1.5, in high-risk individuals?

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →